{"disease":{"id":"opioid-withdrawal-syndrome","name":"opioid withdrawal syndrome"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07278375","title":"Target Trial Emulation for Pharmacologic Treatment of Neonatal Opioid Withdrawal Syndrome","phase":"","overall_status":"RECRUITING","enrollment_count":796,"lead_sponsor_name":"HELP for NOWS Consortium","has_results":false},{"nct_id":"NCT04214834","title":"Trial to Shorten Pharmacologic Treatment of Newborns With Neonatal Opioid Withdrawal Syndrome (NOWS)","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":189,"lead_sponsor_name":"Advancing Clinical Trials in Neonatal Opioid Withdrawal (ACT NOW) Program","has_results":true},{"nct_id":"NCT03918850","title":"Medication Treatment for Opioid Use Disorder in Expectant Mothers","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":140,"lead_sponsor_name":"T. John Winhusen, PhD","has_results":false},{"nct_id":"NCT04834297","title":"Use of SVS Device to Improve Outcomes for Neonatal Opioid Withdrawal Syndrome.","phase":"NA","overall_status":"COMPLETED","enrollment_count":120,"lead_sponsor_name":"Tufts Medical Center","has_results":false},{"nct_id":"NCT03911466","title":"Medication Treatment for Opioid Use Disorder in Expectant Mothers: Conceptual Model Assessments Sub-study","phase":"","overall_status":"COMPLETED","enrollment_count":97,"lead_sponsor_name":"T. John Winhusen, PhD","has_results":false},{"nct_id":"NCT04049799","title":"Maternal Opioid Treatment: Human Experimental Research - Data Yield Appropriate Decisions","phase":"","overall_status":"COMPLETED","enrollment_count":88,"lead_sponsor_name":"University of Vermont","has_results":false},{"nct_id":"NCT05129020","title":"Neurostimulation to Improve NOWS Outcomes","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":52,"lead_sponsor_name":"Spark Biomedical, Inc.","has_results":false},{"nct_id":"NCT05937594","title":"MicroRNA Biomarkers for Neonatal Opioid Withdrawal Syndrome","phase":"","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"Milton S. Hershey Medical Center","has_results":false},{"nct_id":"NCT04298853","title":"Optimal Morphine Dosing Schedule for Neonatal Abstinence Syndrome","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":17,"lead_sponsor_name":"Indiana University","has_results":true},{"nct_id":"NCT04104646","title":"CHF6563 in Babies With Neonatal Opioid Withdrawal Syndrome","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":7,"lead_sponsor_name":"Chiesi Farmaceutici S.p.A.","has_results":true},{"nct_id":"NCT04455802","title":"Randomized Control Trial of Buprenorphine vs. Morphine for the Treatment of Neonatal Opioid Withdrawal Syndrome (NOWS)","phase":"PHASE3","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Women and Infants Hospital of Rhode Island","has_results":false}],"total":11},"guidelines":[],"source":"Drug Landscape verified database"}